A phase II study of gemcitabine plus carboplatin in platinum-sensitive, recurrent ovarian carcinoma.

MLA

Kose, M. F., et al. “A Phase II Study of Gemcitabine plus Carboplatin in Platinum-Sensitive, Recurrent Ovarian Carcinoma.” Gynecologic Oncology, vol. 96, no. 2, Feb. 2005, pp. 374–80. EBSCOhost, https://doi.org/10.1016/j.ygyno.2004.10.011.

APA

Kose, M. F., Sufliarsky, J., Beslija, S., Saip, P., Tulunay, G., Krejcy, K., Minarik, T., Fitzthum, E., Hayden, A., & Melemed, A. (2005). A phase II study of gemcitabine plus carboplatin in platinum-sensitive, recurrent ovarian carcinoma. Gynecologic Oncology, 96(2), 374–380. https://doi.org/10.1016/j.ygyno.2004.10.011

Chicago

Kose, M F, J Sufliarsky, S Beslija, P Saip, G Tulunay, K Krejcy, T Minarik, E Fitzthum, A Hayden, and A Melemed. 2005. “A Phase II Study of Gemcitabine plus Carboplatin in Platinum-Sensitive, Recurrent Ovarian Carcinoma.” Gynecologic Oncology 96 (2): 374–80. doi:10.1016/j.ygyno.2004.10.011.